During the past decade, Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 7 clinical trials were completed, i.e. on average, 53.8% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi" #1 sponsor was "Bayer" with 3 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Laboratoire français de Fractionnement et de Biotechnologies" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator and "Innovative Medicines Initiative (IMI) COMBACTE-CARE (EU)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi" are "Chronic Inflammatory Demyelinating Polyradiculoneuropathy" (2 trials), "Idiopathic Pulmonary Fibrosis" (2 trials), "Psoriasis" (2 trials), "Breast Cancer" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi" in a lesser frequency.

Most popular intervention types in "Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi" are "Drug" (17 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "I10E" (2 trials), "PRM-151 (Zinpentraxin Alfa)" (2 trials), "ASA 100 mg" (1 trials) and "ATM-AVI" (1 trials). Other intervention names were less common.

The vast majority of trials in "Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi" are 15 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".